Azstarys (Dexmethylphenidate/Serdexmethylphenidate) Shortage Update: What Patients Need to Know in 2026

Patients taking Azstarys — the brand name for dexmethylphenidate/serdexmethylphenidate — have found it increasingly difficult to fill prescriptions at local pharmacies. If you've been struggling to find your medication in 2026, this article explains the current status of Azstarys availability, why it can be hard to find even without an official shortage, and what you can do today.

Is Azstarys Currently in an Official Shortage? (2026 Update)

As of early 2026, Azstarys (dexmethylphenidate/serdexmethylphenidate) is NOT listed on the FDA's official drug shortage database. This means the manufacturer (Corium, a Sun Pharmaceutical company) has not reported a formal supply interruption to the FDA.

However, patients regularly report difficulty finding Azstarys at local pharmacies. This is a real and frustrating problem — it's just not an official FDA-declared shortage. The distinction matters because it affects how we understand the problem and what solutions are available.

Why Azstarys Can Be Hard to Find Even Without an Official Shortage

Several structural factors make Azstarys harder to find than many other ADHD medications:

Brand-only, no generic: Serdexmethylphenidate is a novel prodrug with patent protection until at least 2037. No generic is available. This limits competition and means fewer pharmacies maintain routine stock.

ADHD demand surge ripple effects: The ADHD medication shortage that began in October 2022 with Adderall has created sustained demand pressure across all stimulant medications, including Azstarys, as patients seek alternatives.

DEA quota constraints: The DEA sets annual production quotas for Schedule II stimulants, including the dexmethylphenidate component of Azstarys. The DEA increased the methylphenidate quota by about 9% in October 2025 — a step in the right direction, but the effects take months to reach pharmacy shelves.

Low routine stocking: Many pharmacies don't routinely stock brand-only stimulants unless they receive consistent demand. Azstarys was only approved in March 2021 — it's a newer medication with a relatively smaller prescriber base.

What's the Outlook for Azstarys Availability in 2026?

The picture for 2026 is cautiously improving:

DEA quota increases: The DEA raised methylphenidate production quotas in October 2025. This should gradually improve supply for all methylphenidate-class medications, including Azstarys, over the first half of 2026.

Growing prescriber awareness: As Azstarys becomes better known among psychiatrists, pediatricians, and PCPs, more prescriptions are being written — which should encourage more pharmacies to maintain routine stock.

No immediate end to challenges: With no generic alternative expected until 2037 and ongoing ADHD demand growth, patients should continue to expect some variability in Azstarys availability at local pharmacies.

How Does Azstarys Availability Compare to Other ADHD Medications?

Compared to generic Adderall, Focalin XR, and Concerta — which have been formally listed in FDA shortage databases — Azstarys has actually maintained better availability in many regions. Some pharmacists note that Azstarys can often be found at larger chain pharmacies even when other methylphenidate products are backordered. This is partly because fewer total patients are prescribed Azstarys, meaning demand is lower relative to supply. That said, availability remains uneven across ZIP codes and pharmacy chains.

What You Can Do Right Now

If you're struggling to find Azstarys in stock, here are your best options:

Use medfinder: medfinder calls pharmacies near you to locate which ones have Azstarys in stock and can fill your prescription. No more wasted trips.

Fill early within your allowed window: Most insurance plans and state laws allow you to refill a Schedule II stimulant a few days before you run out. Don't wait until your last pill to start looking.

Expand your pharmacy search: Try pharmacies in adjacent ZIP codes. A pharmacy 5–10 miles away may have stock when your closest one doesn't.

Talk to your prescriber: If Azstarys is consistently unavailable, ask your doctor about switching to generic dexmethylphenidate ER (Focalin XR equivalent) as a bridge or permanent alternative.

For more detailed strategies, see our guide: How to Find Azstarys In Stock Near You.